Clinical Differences Between These Weight Loss Injections
Why Mounjaro vs Wegovy Comparison Matters for Prescription Weight Loss
Understanding why Mounjaro might be better than Wegovy requires examining their fundamental mechanisms as prescription weight loss treatments. Mounjaro (tirzepatide) is a dual agonist targeting both GIP and GLP-1 receptors, whilst Wegovy (semaglutide) specifically targets GLP-1 receptors. This dual-hormone approach in Mounjaro may offer different appetite control patterns, though both are prescription-only medicines requiring clinical assessment.
The choice between treatments depends on individual response, medical history, and practical considerations like storage requirements. Both medications work by mimicking natural fullness hormones, reducing appetite, and promoting satiety after smaller meals. Your prescriber at EverydayMeds can evaluate which mechanism aligns best with your weight management goals during our comprehensive clinical assessment process.
Wegovy Pricing and Value for UK Weight Loss Treatment
When considering why Mounjaro vs Wegovy pricing differs, Wegovy offers transparent UK pricing starting at £79.99 for the 0.25mg starter dose. Our Getting Started bundles provide structured progression: the Intro Duo (0.25mg and 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg, and 1.7mg) is £369.99. New customers apply discount code FIRST40 at checkout, with returning customers using DOSE25.
The maintenance dose of 2.4mg is priced at £209.99 per pen, with our Ultimate Stability Trio providing three months' supply for £649.99. This pricing structure reflects Wegovy's established position as a NICE-recommended treatment (TA875) with proven clinical efficacy. Both Wegovy and Mounjaro require the same dose escalation approach, making direct cost comparison dependent on your prescribed pathway and response to treatment.
Clinical Evidence: Mounjaro vs Wegovy Weight Loss Outcomes
The question of why Mounjaro might be better than Wegovy centres partly on clinical trial outcomes, though direct comparison requires careful interpretation. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent efficacy across different patient populations.
Mounjaro's SURMOUNT trials showed different weight loss percentages, but comparing these directly would be misleading due to varying trial designs, patient populations, and endpoints. Both treatments demonstrated significant weight reduction when used as prescription-only medicines alongside lifestyle modifications. Your prescriber can discuss which clinical profile better matches your individual circumstances and weight management goals.
How Wegovy Works as a Weight Management Treatment
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals, and potentially reducing food cravings throughout the day. The once-weekly FlexTouch injection provides consistent hormone levels, supporting sustained appetite control between doses. Unlike Mounjaro's dual-hormone approach, Wegovy's single-pathway mechanism offers targeted GLP-1 receptor stimulation. This focused action has been extensively studied in the STEP trial programme, establishing Wegovy's efficacy profile for long-term weight management when combined with reduced-calorie diet and increased physical activity.
EverydayMeds Ordering Process for Weight Loss Prescriptions
Starting your weight loss treatment comparison begins with our 3-minute online clinical assessment, designed to capture essential medical history and current health status. Our UK-qualified prescribers review applications within 3 working days as standard, with express 24-hour review available for urgent cases. Once approved, your prescription-only medicine is prepared by our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using temperature-controlled cold-chain logistics. This process ensures both Wegovy and Mounjaro maintain therapeutic efficacy from our pharmacy to your door. Whether you're comparing why Mounjaro might be better than Wegovy or seeking specific treatment guidance, our clinical team provides personalised recommendations based on your individual assessment results.
Storage and Practical Considerations in Treatment Choice
Storage requirements may influence why Mounjaro vs Wegovy comparisons favour one treatment over another for certain lifestyles. Wegovy offers superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage benefits frequent travellers or those with limited refrigeration access. Both treatments require initial storage at 2-8°C and use similar injection techniques with pre-filled pens. The dose escalation schedule is comparable between treatments: starting low and gradually increasing over 16 weeks to reach maintenance dosing. Wegovy's FlexTouch pen design provides clear dosing indicators and safety features standard across Novo Nordisk's injection systems.
Individual Response Patterns: Why Treatment Choice Varies
The question of why Mounjaro might be better than Wegovy for prescription weight loss often comes down to individual response patterns and tolerance profiles. Some patients respond more favourably to dual-hormone targeting, whilst others achieve optimal results with single-pathway GLP-1 stimulation. Side effect profiles, though similar between treatments, can vary in intensity and duration for individual patients.
Wegovy's established UK pathway includes specialist weight management support as recommended by NICE (TA875), providing structured clinical oversight throughout treatment. This comprehensive approach addresses not just medication efficacy but long-term weight maintenance strategies. Both treatments are prescription-only medicines requiring ongoing clinical monitoring, making the choice highly dependent on your prescriber's clinical judgement and your personal treatment goals and circumstances.
Making Your Treatment Decision Through EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to determine which treatment aligns best with your individual needs and medical history. Our clinical assessment captures relevant factors including previous weight loss attempts, current medications, and lifestyle considerations that influence treatment selection. Rather than determining why Mounjaro is definitively better than Wegovy, our approach focuses on personalised treatment matching. Complete your assessment today using discount code FIRST40 for new customers, and let our qualified prescribers guide your weight loss treatment journey with evidence-based recommendations.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
